Compounded Semaglutide

Active Ingredient in Ozempic® and Wegovy®

AS LOW AS
$ 179 /month

Benefits

  • Improves your energy, mood, and sleep
  • Helps you feel fuller for longer by reducing appetite and hunger
  • Reduces health-related diseases

Program Summary

Initial Telehealth Visit
Real-time Physician Support
Prescription + Medication
Remote Monthly Check-ins

Compounded Tirzepatide

Active Ingredient in Mounjaro® and Zepbound®

AS LOW AS
$ 299 /month

Benefits

  • Reduces appetite and hunger
  • Slows stomach emptying and helps you feel fuller, longer
  • Helps control blood sugars

Program Summary

Initial Telehealth Visit
Real-time Physician Support
Prescription + Medication
Remote Monthly Check-ins

What You Need To Know About
Semaglutide

  • What is Semaglutide?

    Semaglutide is the active ingredient in injectable weight-loss medication. It was FDA-approved in 2017 for Type 2 diabetes under the brand name Ozempic® and later found to be beneficial for weight loss. It was FDA-approved in 2021 for weight loss as Wegovy®, achieving an average of 15% weight loss. Semaglutide is the active ingredient in both Ozempic® and Wegovy®, but the two are sometimes administered at different doses.

  • How does Semaglutide Work?

    Semaglutide mimics a hormone known as glucagon-like peptide-1 (GLP-1) which is naturally produced in your intestines. It sends signals to your brain to reduce hunger, slows down how quickly food leaves your stomach, and encourages your pancreas to produce more insulin which helps lower your blood sugar levels. These effects work together to support weight loss.

  • What are the benefits of Semaglutide?

    Semaglutide has been observed to lead to weight loss of about 15%, with the weight loss being sustained. Health benefits associated with weight loss include improvements in energy, mood, and sleep, along with a reduction in heart disease, improvements in diabetes, blood sugar control, blood pressure control, cholesterol levels, kidney health, and fatty liver disease.

  • What are side effects I should be aware of?

    Side effects are typically mild and can include nausea, vomiting, diarrhea, and constipation. These side effects usually subside within 2-3 weeks, with nausea being considered an “on target” side effect that helps reduce your caloric intake. Less common but more serious side effects can include allergic reactions, low blood sugar, kidney problems (especially if you are very dehydrated), gallstones and pancreatitis. Thyroid tumors or cancer has been observed in rodents, but not yet humans.

  • Who should avoid Semaglutide?

    You should avoid semaglutide if any of the following conditions apply to you:

    • You are pregnant
    • You have an allergic reaction to semaglutide or any of its ingredients
    • You have a personal or family history of medullary thyroid carcinoma
    • You have a personal or family history of multiple endocrine neoplasia syndrome type 2
  • How do I take Semaglutide?

    Semaglutide is injected under the skin either in the thigh, upper arm, or abdomen. Make sure you rotate the injection site each week. Semaglutide can be taken with or without food, at any time of day. You should take the injection consistently on the same day each week. If you need to adjust the day of injection, try to avoid injecting within two days of a prior injection. When you forget a dose, make sure to take it within five days of the expected injection day.

  • What does the treatment plan generally look like?

    The standard, FDA-approved dosing schedule for semaglutide is:

    • Month 1: 0.25 mg per week
    • Month 2: 0.5 mg per week
    • Month 3: 1 mg per week
    • Month 4: 1.7 mg per week
    • Month 5: 2.4 mg per week

    Most patients start at the lowest dose in the first month, then steadily increase every month until you have found the right dose that fits your needs. 1.7 mg and 2.4 mg doses are considered maintenance doses.

  • What foods should I avoid?

    You are not expected to make strict dietary changes during the plan, but most patients naturally consume fewer calories.

    As constipation is a side effect to look out for, we recommend having a diet rich in fiber and drinking plenty of water, as doing so can minimize constipation.

  • Am I required to exercise?

    We recommend you to exercise while on semaglutide, but it is not required. You may lose muscle mass while losing weight, and exercising regularly helps retain your muscle mass and fitness.

What You Need To Know About
Tirzepatide

  • What is Tirzepatide?

    Tirzepatide is the active ingredient in injectable weight-loss medication. It was FDA-approved in 2021 for Type 2 diabetes under the brand name Mounjaro and later found to be beneficial for weight loss. It was FDA-approved in 2023 for weight loss as Zepbound. Tirzepatide is the active ingredient in both Mounjaro and Zepbound.

  • How does Tirzepatide work?

    Tirzepatide mimics two naturally produced hormones in your body, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Its activity works to send signals to your brain to reduce hunger, slows down how quickly food leaves your stomach, and has hormonal effects to improve your metabolism. Together, these effects work to support weight loss.

  • What are the benefits of Tirzepatide?

    Tirzepatide has been observed to lead to weight loss of about 21%, with the weight loss being sustained. Health benefits associated with weight loss include improvements in energy, mood, and sleep, along with a reduction in heart disease, improvements in diabetes, blood sugar control, blood pressure control, cholesterol levels, kidney health, and fatty liver disease.

  • What are side effects I should be aware of?

    Side effects are typically mild and can include nausea, vomiting, diarrhea, and constipation. These side effects usually subside within 2-3 weeks, with nausea being considered an “on target” side effect that helps reduce your caloric intake.

    Less common but more serious side effects can include allergic reactions, low blood sugar, kidney problems (especially if you are very dehydrated), gallstones and pancreatitis. Thyroid tumors or cancer has been observed in rodents, but not yet humans.

  • Who should avoid Tirzepatide?

    You should avoid tirzepatide if any of the following conditions apply to you:

    • You are pregnant
    • You have an allergic reaction to tirzepatide or any of its ingredients
    • You have a personal or family history of medullary thyroid carcinoma
    • You have a personal or family history of multiple endocrine neoplasia syndrome type 2
  • How do I take Tirzepatide?

    Tirzepatide is injected under the skin either in the thigh, upper arm, or abdomen. Make sure you rotate the injection site each week. Tirzepatide can be taken with or without food, at any time of day. You should take the injection consistently on the same day each week. If you need to adjust the day of injection, try to avoid injecting within two days of a prior injection. When you forget a dose, make sure to take it within four days of the expected injection day.

  • What does the treatment plan generally look like?

    The standard, FDA-approved dosing schedule for tirzepatide is:

    • Month 1: 2.5 mg per week
    • Month 2: 5 mg per week
    • Month 3: 7.5 mg per week
    • Month 4: 10 mg per week
    • Month 5: 12.5 mg per week
    • Month 6: 15 mg per week

    Most patients start at the lowest dose in the first month, then steadily increase every month until you have found the right dose that fits your needs. 10 mg, 12.5 mg, and 15mg doses are considered maintenance doses.

  • What foods should I avoid?

    You are not expected to make strict dietary changes during the plan, but most patients naturally consume fewer calories.

    As constipation is a side effect to look out for, we recommend having a diet rich in fiber and drinking plenty of water, as doing so can minimize constipation.

  • Am I required to exercise?

    We recommend you to exercise while on tirzepatide, but it is not required. You may lose muscle mass while losing weight, and exercising regularly helps retain your muscle mass and fitness.

1. Jastreboff et al.; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216.
We Are LegitScript Certified!

LegitScript only works with organizations that have ensured patients receive the highest quality of care.